CSAM Health Group AS(DE:6Q1)
€4.22-0.12 (-2.76%)
DE:6Q1
CSAM Health Group AS financials statements
€4.22
At close:-0.12 (-2.76%)
CSAM Health Group AS (6Q1) Ratios
0 Followers
CSAM Health Group AS Ratios
DE:6Q1's free cash flow for Q2 2026 was kr1.34M. For the 2026 fiscal year, DE:6Q1's free cash flow was decreased by kr-619.00K and operating cash flow was kr1.96M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.78 | 0.82 | 1.31 | 1.96 | 2.51 |
| Quick Ratio | 0.78 | 0.82 | 1.31 | 1.96 | 2.51 |
| Cash Ratio | 0.36 | 0.46 | 0.70 | 1.33 | 1.77 |
| Solvency Ratio | 0.09 | -0.01 | 0.26 | -0.06 | -0.01 |
| Operating Cash Flow Ratio | 0.12 | 0.52 | 0.23 | 0.08 | 0.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr -596.71M | kr -559.38M | kr -454.50M | kr -382.41M | kr -254.51M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.61 | 0.61 | 0.62 | 0.71 | 0.60 |
| Debt-to-Equity Ratio | 18.33 | 28.33 | 5.01 | 17.18 | 2.95 |
| Debt-to-Capital Ratio | 0.95 | 0.97 | 0.83 | 0.95 | 0.75 |
| Long-Term Debt-to-Capital Ratio | 0.95 | 0.97 | 0.83 | 0.95 | 0.75 |
| Financial Leverage Ratio | 30.19 | 46.20 | 8.08 | 24.10 | 4.89 |
| Debt Service Coverage Ratio | 1.68 | 0.82 | 4.44 | -0.04 | 0.71 |
| Interest Coverage Ratio | 0.79 | -0.20 | 2.42 | -2.01 | -1.61 |
| Debt to Market Cap | 0.52 | 0.71 | 0.63 | 0.62 | 0.27 |
| Interest Debt Per Share | 26.85 | 26.51 | 25.98 | 25.35 | 24.71 |
| Net Debt to EBITDA | 3.52 | 7.74 | 1.58 | -47.46 | 10.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.95% | 92.70% | 92.20% | 90.90% | 89.26% |
| EBIT Margin | 9.85% | -2.09% | 38.13% | -27.04% | -13.06% |
| EBITDA Margin | 23.30% | 11.11% | 55.52% | -1.74% | 6.45% |
| Operating Profit Margin | 9.85% | -2.84% | 31.35% | -20.39% | -13.06% |
| Pretax Profit Margin | 3.68% | -16.33% | 25.18% | -37.18% | -26.37% |
| Net Profit Margin | 1.34% | -15.70% | 25.42% | -35.89% | -27.06% |
| Continuous Operations Profit Margin | 1.34% | -15.70% | 27.22% | -35.89% | -27.06% |
| Net Income Per EBT | 36.32% | 96.18% | 100.95% | 96.53% | 102.65% |
| EBT Per EBIT | 37.37% | 574.32% | 80.33% | 182.37% | 201.82% |
| Return on Assets (ROA) | 0.82% | -8.47% | 13.57% | -18.97% | -10.93% |
| Return on Equity (ROE) | 24.78% | -391.31% | 109.55% | -457.37% | -53.49% |
| Return on Capital Employed (ROCE) | 8.53% | -2.27% | 21.39% | -13.60% | -6.54% |
| Return on Invested Capital (ROIC) | 3.10% | -2.19% | 21.39% | -13.13% | -6.54% |
| Return on Tangible Assets | 3.00% | -26.29% | 39.86% | -40.93% | -20.10% |
| Earnings Yield | 0.70% | -9.86% | 13.81% | -16.52% | -4.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.05 | 6.78 | 6.44 | 4.06 | 0.00 |
| Payables Turnover | 24.31 | 1.27 | 1.78 | 2.90 | 1.74 |
| Inventory Turnover | 7932.65 | 121.69 | 681.06 | 102.08 | 5052.57 |
| Fixed Asset Turnover | 74.26 | 48.14 | 44.53 | 40.13 | 40.51 |
| Asset Turnover | 0.61 | 0.54 | 0.53 | 0.53 | 0.40 |
| Working Capital Turnover Ratio | -10.14 | 122.01 | 4.32 | 1.95 | 1.37 |
| Cash Conversion Cycle | 57.36 | -230.06 | -148.36 | -32.37 | -210.03 |
| Days of Sales Outstanding | 72.33 | 53.84 | 56.69 | 89.82 | 0.00 |
| Days of Inventory Outstanding | 0.05 | 3.00 | 0.54 | 3.58 | 0.07 |
| Days of Payables Outstanding | 15.02 | 286.90 | 205.58 | 125.77 | 210.11 |
| Operating Cycle | 72.37 | 56.84 | 57.22 | 93.40 | 0.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.40 | 6.45 | 1.91 | 0.55 | 1.05 |
| Free Cash Flow Per Share | 1.31 | 4.30 | -0.36 | -1.44 | -0.32 |
| Dividend Paid and CapEx Coverage Ratio | 15.72 | 2.46 | 0.84 | 0.28 | 0.77 |
| Capital Expenditure Coverage Ratio | 15.72 | 3.00 | 0.84 | 0.28 | 0.77 |
| Operating Cash Flow Coverage Ratio | 0.06 | 0.27 | 0.08 | 0.02 | 0.04 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.31 | 0.09 | 0.03 | 0.07 |
| Free Cash Flow Yield | 2.84% | 13.04% | -0.98% | -3.79% | -0.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 144.06 | -10.15 | 7.24 | -6.05 | -20.23 |
| Price-to-Sales (P/S) Ratio | 1.91 | 1.59 | 1.84 | 2.17 | 5.48 |
| Price-to-Book (P/B) Ratio | 35.45 | 39.69 | 7.93 | 27.69 | 10.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 35.27 | 7.67 | -101.57 | -26.37 | -271.04 |
| Price-to-Operating Cash Flow Ratio | 33.02 | 5.12 | 19.42 | 68.48 | 82.03 |
| Price-to-Earnings Growth (PEG) Ratio | -1.31 | 0.06 | -0.04 | -0.13 | -0.02 |
| Enterprise Value Multiple | 11.73 | 22.08 | 4.90 | -172.40 | 94.97 |
| Enterprise Value | 1.35B | 1.04B | 1.12B | 1.10B | 2.02B |
| EV to EBITDA | 11.73 | 22.08 | 4.90 | -172.40 | 94.97 |
| EV to Sales | 2.73 | 2.45 | 2.72 | 3.00 | 6.13 |
| EV to Free Cash Flow | 50.38 | 11.82 | -150.01 | -36.38 | -303.19 |
| EV to Operating Cash Flow | 47.17 | 7.88 | 28.68 | 94.49 | 91.77 |
| Tangible Book Value Per Share | -27.21 | -25.21 | -20.18 | -16.37 | -9.79 |
| Shareholders’ Equity Per Share | 1.30 | 0.83 | 4.66 | 1.37 | 7.95 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.64 | 0.04 | -0.08 | 0.03 | -0.03 |
| Revenue Per Share | 24.10 | 20.72 | 20.10 | 17.49 | 15.71 |
| Net Income Per Share | 0.32 | -3.25 | 5.11 | -6.28 | -4.25 |
| Tax Burden | 0.36 | 0.96 | 1.01 | 0.97 | 1.03 |
| Interest Burden | 0.37 | 7.82 | 0.66 | 1.38 | 2.02 |
| Research & Development to Revenue | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.04 | 0.05 | 0.05 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 4.33 | -1.91 | 0.38 | -0.09 | -0.25 |
Currency in NOK

